All fields are required.

Close Appointment form

About Us

FOMAT Medical Research is pioneering clinical research in Ecuador, Colombia, Peru and Latin America. We are directing the clinical research departments for several of the largest hospitals throughout the Americas. In Latin America, FOMAT is acknowledged as a Site Network Organization (SNO) with local Contract Research Organization (CRO) capabilities. Diversifying clinical research is a top priority at FOMAT, which is why collecting data from Hispanic sites is essential. Data is gathered through our numerous clinical sites located in Ecuador,the United States, Colombia and Peru.

Diverse Research Solutions (DRS) is an American SMO,
headquartered in Oxnard, California. As a SMO, we have over 10
years of experience conducting a wide range of clinical trials
inside and outside of the country.

We have acquired the professional expertise to assist pharmaceutical
companies and CROs in reaching their project goals
quickly and effectively. Throughout our work we have specialized
and mastered Phase 2 & Phase 3 clinical trials.

FOMAT and DRS share the same mission: to diversify and include everyone on high quality clinical trials managed throughout the Americas ensuring that GCP standards and bioethics are upheld and used to contribute valuable data to the scientific community.
In FOMAT and DRS, we believe that the future lies in innovation.
Therefore, we are determined to facilitate drug development so that medicine can become available and reach people who need them faster. We have developed capabilities with additional benefits that only FOMAT-DRS can
offer you during your clinical trials.

To sponsors and CROs:
We are committed to high quality management of clinical trials which will improve and innovate healthcare for everybody around the world and improve outcomes of clinical research through the diversification of research populations.

To the patients and volunteers:

We are committed to helping and serving people and underrepresented populations and to help improve the outcome of clincal research by diversifying research populations.